Prognostic significance of PSA>0.2 after 6-12 months treatment for metastatic hormone-sensitive prostate cancer (mHSPC) intensified by androgen-receptor pathway inhibitors (ARPI): A multinational real-world analysis of the IRONMAN registry. Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Ong, Michael
  • Roy, Soumyajit
  • Chi, Kim N
  • Dorff, Tanya B
  • Hotte, Sebastien
  • Wyatt, Alexander William
  • Howard, Lauren
  • Autio, Karen A
  • Enting, Deborah
  • Omlin, Aurelius Gabriel
  • Mateo, Joaquin
  • McDermott, Raymond S
  • Davis, Ian D
  • Bjartell, Anders
  • Cannon, Laurel
  • Chan-Cuzydlo, Alyssa
  • Kantoff, Philip W
  • Mucci, Lorelei A
  • George, Daniel J

publication date

  • June 2025